Iodide

Iodide

SCHEMBL163134

I.[Ra]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Radium Ra-223 SCHEMBL29368855 0.71
Radium SCHEMBL30265712 0.71
Iodide SCHEMBL526 0.71
Iodide SCHEMBL5037302 0.71
Iodide SCHEMBL2757576 0.71
Iodide SCHEMBL498519 0.71
Iodide SCHEMBL42205 0.71
Iodide SCHEMBL6053672 0.71
Iodide SCHEMBL21886 0.71
Strontium SCHEMBL30538689 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505639-B2 Sulfate molecule removal through inorganic or divalent ion nuclei seeding SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2016-11-29 US claimed
US-9005357-B2 Method of preparing molybdenum oxide films AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-04-14 US claimed
US-20130313534-A1 METHOD OF PREPARING MOLYBDENUM OXIDE FILMS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-11-28 US claimed
US-8110124-B2 Method of preparing fluorescent body precursor KURARAY CO., LTD. (JP) 2012-02-07 US claimed
US-12319815-B2 Resin composition, method for producing same, and multi-liquid curable resin composition KANEKA CORPORATION (JP) 2025-06-03 US disclosed
US-12312494-B2 Resin composition, method for producing same, and multi-liquid curable resin composition KANEKA CORPORATION (JP) 2025-05-27 US disclosed
WO-2025087481-A1 SYSTEM AND METHOD FOR PRODUCING RADIONUCLIDES ERT GMBH (DE) 2025-05-01 WO disclosed
WO-2024261882-A1 CONDOM AND METHOD FOR MANUFACTURING SAME 山口 玄二 2024-12-26 WO disclosed
CN-110366597-B Blood profiling with protease inhibitors 善威生物私人有限公司 2024-03-29 CN disclosed
US-20240060997-A1 Blood Preparation and Profiling SANGUI BIO PTY LTD (AU) 2024-02-22 US disclosed
WO-2024017826-A2 METHODS FOR PURIFYING RECOMBINANT POLYPEPTIDES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2024-01-25 WO disclosed
CN-115003759-B Resin composition, method for producing same, and multicomponent curable resin composition 株式会社钟化 2023-12-01 CN disclosed
WO-2012050945-A1 CATIONIC DRY POWDERS PULMATRIX, INC. (US) 2012-04-19 WO disclosed
US-20120064126-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX, INC. (US) 2012-03-15 US disclosed
WO-2012030664-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX, INC. (US) 2012-03-08 WO disclosed
EP-2410981-A2 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES Pulmatrix, Inc. (US) 2012-02-01 EP disclosed
WO-2010111680-A2 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX, INC. (US) 2010-09-30 WO disclosed
US-20090093593-A1 RUBBER COMPOSTITION AND PNEUMATIC TIRE USING SAME BRIDGESTONE CORPORATION (JP) 2009-04-09 US disclosed
EP-1829934-A1 RUBBER COMPOSITION AND PNEUMATIC TIRE USING SAME Bridgestone Corporation (JP) 2007-09-05 EP disclosed
US-4339617-A Hydration of olefins in the presence of a corrosion inhibitor UOP INC. (US) 1982-07-13 US disclosed